[ad_1] By Cynthia McCormick Hibbert, Northeastern College Human security trials of a novel antibiotic therapy for Lyme disease developed by Northeastern professor Kim Lewis are scheduled to start out this spring in Australia, with outcomes anticipated by fall. “Hopefully, the outcomes shall be constructive,” says Lewis, College Distinguished Professor of Biology. To this point the […]